Inside the deal: GTCR eyes add-ons for new life sciences platform PathGroup

“We have identified a number of potential acquisitions and we have a nice pipeline,” said GTCR's Sean Cunningham.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this